Co-Diagnostics, Inc. SEC filings CODX

Co-Diagnostics, Inc. has 390 filings in SEC EDGAR's recent list, going back to Dec 29, 2016. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Co-Diagnostics, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Oct 26, 2026 Oct 26, 2026
PRE 14A Preliminary proxy statement Oct 16, 2026 Oct 16, 2026
PRE 14A Preliminary proxy statement Sep 21, 2026 Sep 21, 2026
DEFA14A Additional proxy material Sep 4, 2026 —
DEF 14A Proxy statement Jul 21, 2026 Jul 21, 2026
PRE 14A Preliminary proxy statement Jul 10, 2026 Jul 9, 2026
DEF 14A Proxy statement Nov 10, 2025 Nov 10, 2025
PRE 14A Preliminary proxy statement Oct 31, 2025 Oct 31, 2025
DEF 14A Proxy statement Apr 14, 2025 Dec 31, 2024
DEF 14A Proxy statement Jul 16, 2024 Jul 16, 2024
DEF 14A Proxy statement Jul 20, 2023 Jul 20, 2023
DEF 14A Proxy statement Jul 20, 2022 Jul 20, 2022
DEF 14A Proxy statement Jun 22, 2021 Jun 22, 2021
DEFA14A Additional proxy material Nov 3, 2020 —
DEF 14A Proxy statement Nov 3, 2020 Nov 3, 2020
DEF 14A Proxy statement Aug 9, 2019 Aug 9, 2019
DEF 14A Proxy statement Dec 12, 2018 Dec 12, 2018
PRE 14A Preliminary proxy statement Nov 30, 2018 Nov 30, 2018

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
CODX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
UT
Headquarters
Salt Lake City, UT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1692415

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.